France· FR:69963066
JARDIANCE 25 mg, comprimé pelliculé
A medicinal product containing empagliflozine, registered in France by BOEHRINGER INGELHEIM INTERNATIONAL, on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- EMPAGLIFLOZINE
- Manufacturer
- BOEHRINGER INGELHEIM INTERNATIONAL
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip13340092789291230 plaquette(s) thermoformée(s) PVC-Aluminium de 1 comprimé(s)EUR 36.59
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Empagliflozine in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaEMPAGLIFLOZIN POLPHARMAZaklady Farmaceutyczne Polpharma SA, Starogard Gdański
- NetherlandsEmpagliflozine Devatis 25 mg, filmomhulde tablettenDevatis GmbH
- United StatesJardianceA-S Medication Solutions
- SwedenEmpagliflozin Devatis 25 mg Filmdragerad tablettDevatis GmbH
- SpainEMPAGLIFLOZINA AUROVITAS 25 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFGAurovitas Spain, S.A.U.
- BelgiumEmpagliflozin AB 25 mgAurobindo
- FinlandEmpagliflozin DevatisDevatis GmbH
- IcelandEmpagliflozin ReddyReddy Holding GmbH
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Empagliflozin Denk, Empagliflozin Devatis
- Belgium · Empagliflozin Ab, Empagliflozine Hcs
- Bulgaria · Глузод, Емлигекса
- Cyprus · Glusod
- Czechia · Empagliflozin Polpharma, Empelic
- Germany · Empagliflozin Devatis, Emprables
- Denmark · Bifoglan, Elemio
- Estonia · Glusod
- Spain · Empagliflozina Aurovitas, Empagliflozina Kern Pharma
- Finland · Empagliflozin Devatis, Empagliflozin Reddy
- United Kingdom (Northern Ireland) · Empagliflozin, Empagliflozin G.L. Pharma
- Greece · Elemio, Empagliflozin Pharmapath
- Croatia · Glusod
- Hungary · Empagliflozin Polpharma
- Ireland · Empagliflozin Krka
- Iceland · Empagliflozin Reddy, Empagliflozin Wh 10 Mg
- Liechtenstein · Jardiance
- Lithuania · Embeflyx, Emlygexa
- Luxembourg · Empagliflozin Ab
- Latvia · Embeflyx, Emlygexa
- Malta · Empagliflozin Denk, Eprekavor
- Netherlands · Empagliflozine Devatis, Empagliflozine Doc
- Norway · Empagliflozin Devatis, Empagliflozin Reddy
- Poland · Empelic
- Portugal · Empagliflozina Aurobindo, Empagliflozina Aurovitas
- Romania · Glusod
- Sweden · Empagliflozin Devatis, Empagliflozin Labiana
- Slovenia · Empagliflozin Krka, Glusod
- Slovakia · Empagliflozin Polpharma, Glusod
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f6d532c7-dee0-4bdf-80e6-4b329a95d9d7 GET /v1/drugs/f6d532c7-dee0-4bdf-80e6-4b329a95d9d7?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "69963066",
"date_amm": "2014-05-22",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/14/930",
"substance": "EMPAGLIFLOZINE",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "comprimé pelliculé",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about empagliflozine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.